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Introduction
As the incidence of breast cancer continues to rise 1 , more women are undergoing mastectomy and breast reconstruction 2 . Autologous tissue breast reconstruction offers the greatest patient satisfaction 3 , so its use is gaining popularity worldwide 4 with the deep inferior epigastric perforator (DIEP) flap evolving as the ideal choice for autologous reconstruction in suitable women. Breast reconstruction with DIEP flap(s) is associated with lower risks of adverse outcomes 5 , favourable donor site morbidity [6] [7] [8] [9] , improved quality of life 10 , shorter hospital stay 11, 12 , reduced postoperative pain [13] [14] [15] and superior cosmetic results
16
, compared to breast reconstruction using other flaps and a substantially lower risk of failure when compared to implants 5, 17, 18 .
To reduce the risk of complications and improve the efficiency of flap harvest, many surgeons use preoperative perforating mapping of the lower abdominal wall. Current options 19 include: duplex ultrasound; computed tomography angiography (CTA) with intravenous iodinated contrast and magnetic resonance angiography (MRA) with intravenous gadolinium. Recent reviews have shown that perforator mapping significantly reduces the risks of total and partial flap failure 20 as well as hospital stay 21 . Axial imaging with CTA/MRA also provides an opportunity to detect 'incidentalomas' or occult recurrence 19 , which could substantially change management [22] [23] [24] .
Further, Offodile and colleagues 25 showed that perforator mapping by CTA was cost-effective given morbidity reductions and improved quality of life when compared to DIEP flap breast reconstruction without preoperative imaging, which is associated with higher risks of complication.
However, to-date there is no reliable evidence that perforator mapping reduces operating time.
Reducing operating time has the potential to confer considerable cost-savings, reduce morbidity and therefore, improve patient outcomes.
We aimed to investigate the hypothesis that preoperative perforator mapping by ultrasound, CTA or MRA prior to DIEP flap breast reconstruction, reduces operating time.
are constant) are likely to be due to reductions in the flap harvesting time. Further, time is a scaled outcome with ratio property, so between-group differences in flap harvest time will be equal to differences in total operative time again supporting the concept that pooling is acceptable.
Observational research rarely generates similar baseline groups, so we planned to use adjusted estimates of operating time. Secondary outcomes included total flap failure (defined as failure which required removal of the entire flap) and partial flap failure (defined as failure of a portion of the flap which required debridement but not complete removal), recorded as binary outcomes.
Data extraction
We extracted details of the study design and the statistics for operating time, flap harvest time or any permutation of these alongside the frequency of total flap loss and partial flap loss. Where data was missing or unclear, we contacted the corresponding author by email and/or phone and if no reply was received, then 4 weeks later all authors were contacted in addition to re-contacting the corresponding author. 
Assessment of Bias
The risk of methodological bias was assessed by two review authors independently, using the ROBINS-I tool 38 . Similarly, the overall quality of the evidence was independently assessed by two review authors using the GRADE tool 39 .
Analysis
We performed direct comparison meta-analyses using Review Manager® version 5 (The Nordic
Cochrane Centre, The Cochrane Collaboration, 2014) to calculate mean differences in operating time and relative risk ratios (RR) for adverse outcomes with 95% confidence intervals (CI), using the inverse variance and Mantel-Haenszel tests, respectively. Random-effects models were used for except one analysis, due to statistical heterogeneity as quantified by the I 2 statistic. The patient/woman was the unit of analysis and not the flap 40, 41 . Significance was set as 5%. There was insufficient data for any meaningful assessment of publication bias.
Results
We included 14 articles 35-37,42-44,21,45-50 (Figure 1 ), the characteristics of which are summarised in Table 1 .
Preoperative perforator mapping by CTA or MRA saved a mean of 54 minutes (95% CI 3 to 105 minutes, Figure 2 ). However, there was significant statistical heterogeneity, all studies were at high risk of methodological biases and the quality of the evidence is very low (GRADE score +1;
downgraded once for methodological concerns).
Subgroup analyses in Figure 3 show that perforator mapping by CTA appears superior to ultrasound, given that CTA reduced operating time by a mean of 58 minutes (95% CI 25 to 91 minutes). Again, there was significant statistical heterogeneity, all studies were at risk of methodological biases and the quality of the evidence is very low (GRADE score 0; downgraded once for methodological concerns and once for consistency). We performed a sensitivity analysis by removing studies at high risk of methodological bias 42,36,44 and CTA remained superior to ultrasound (saving a mean of 72 minutes [95% CI 33, 112], p<0.001).
The risk of total flap loss was not different between women who had perforator mapping by CTA or ultrasound ( Figure 4 ). All studies were at risk of methodological biases and the quality of this evidence is very low (GRADE score +1; downgraded once for methodological concerns).
The risk of partial flap loss was 80% lower when perforator mapping was performed by CTA (RR 0.2 [95% CI 0.04 to 0.6]; Figure 5 ). A sensitivity analysis performed by removing the study 34 at high risk of methodological bias strengthened this association, such that CTA perforator mapping again appeared to reduce the risk of partial flap loss. The absence of statistical heterogeneity improves the confidence in this estimate and justifies the choice for a fixed-effects model. However, the quality of the evidence is again very low (GRADE score +1; downgraded once for methodological concerns). to perform meta-analysis of the risks of total or partial flap loss for women undergoing bilateral DIEP flap breast reconstruction. All included studies reporting the outcomes of bilateral reconstruction were at high risk of methodological bias and the quality of the evidence is very low (GRADE score +1; downgraded once for methodological concerns).
Risk of bias
All studies were at risk of methodological biases ( Figure 6 ) and this limits the external validity of our findings. Our reasons for declaring some studies at high risk of bias in certain domains are as follows:
 Five studies were missing standard deviations 48, 51, 37, 45, 46 which prevents inference about the spread of data and required imputation for this review, which will bias the results towards no effect and as such, we designated these studies at high risk of bias due to missing data.
 Casey et al 42 tabulated baseline between-group differences but omitted the p-values from the following tests of proportion: operating surgeons A vs. B vs. C, unilateral vs. bilateral reconstructions and; immediate vs. delayed cases. We analysed these proportions and they represent significant baseline imbalances (p<0.001, p=0.005 and p=0.0001, respectively) which could confound the outcome. It is unclear why these comparisons were omitted, so we have graded this study at high risk of 'bias due to confounding' and 'bias in the selection of reported results'.
 Klasson et al 44 was graded as high risk of 'bias in selection of the reported results' given that there was one case lost to follow-up in the CTA group but incomplete data is still reported, and one case in the ultrasound group was excluded as the operation was very long and designated an outlier.
 We judged Minqiang et al to be at high risk of methodological bias in several domains.
Three DIEPs were converted to SIEA/TRAM flaps but included in the DIEP group analyses (which is reflected in the judgement of high risk of 'bias in classicisation of the intervention') and this may bias the outcome in favour of mapping because SIEA and TRAM flaps are typically easier (and so faster) to harvest. , the potential cost savings per annum is approximately £0.5million. However, differences in the observed operating time between groups could also be explained by methodological biases or confounding variables, both of which are certainly present in the included studies. For those wishing to setup a perforator mapping service, we provide the scanning protocols for included studies in Appendix 1 (supplementary online material). We invite further prospective research and economic analyses into the potential improved cost utility 58 of perforator mapping prior to DIEP flap breast reconstruction; ideally, these would be investigated in randomised trials.
The benefits of perforator mapping must be weighed against the potential risks of medical imaging.
Safety is of paramount importance and whilst ultrasound may be inferior to CTA/MRA in many ways, ultrasound remains popular because it is universally considered to be safe. Conversely, a typical CTA of the lower abdominal wall delivers 6-10 millisieverts (mSv), which does incur a statistically small but significantly increased risk of developing a de-novo cancer 59, 60 . Rozen extrapolated this to infer that approximately 1 in 1050 women would develop an extra cancer attributable to mapping CTA (at 8.18mSv) 61 . Whilst magnetic resonance imaging does not pose any biological risk 62 , there are absolute contra-indications (metal in the eyes or brain given the risk of haemorrhage or visual loss respectively, and implants which are not "MR-safe" given the risk of burns or dysfunction), relative contra-indications (such as pregnancy 63 and claustrophobia) and common side effects such as nausea, vertigo and temporary neuro-behavioural changes.
Intravenous gadolinium was used in all included articles and provides the chief unpredictable risk for patients; gadolinium shorten the T1, improving fluid signal albeit not a 'contrast medium' in the strictest sense. Whilst old formulations of gadolinium conferred a small risk of nephrogenic systemic fibrosis owing to Gd 3+ deposition, subsequent formulations based on a stronger chelator (DTPA) have all-but eliminated this concern. All current gadolinium based agents pose a dosedependent risk of adverse reaction with 1 in 100 being affected; most are transient hypersensitivity reactions but there is a 3 in 10,000 risk of death from anaphylaxis, typically affecting women with drug hypersensitivities. 64 Therefore, whilst CTA and MRA may provide more useful information than ultrasound, there are risks which must be considered. To better explore this topic, we recommend a systematic review and meta-analysis of the diagnostic accuracy of CTA versus MRA for the identification of the dominant perforator in unilateral DIEP flap breast reconstruction. Once the best test (CTA or MRA) is defined, then the cost utility can be better investigated and policy recommendations made.
Limitations
Heterogeneity in the outcomes is important to consider because observed differences in the outcome may derive from statistical and/or clinical differences, which in-turn may confound the outcome. Regarding the differences in operative time associated with perforator mapping ( Figure   2 ) -heterogeneity may explain this difference, with baseline between-group differences favouring the mapping group, for example the mapping group may more: slimmer patients in which flap harvest is easier; patients operated on by senior (and so efficient) surgeons; immediate reconstructions which are quicker because the breast pocket and recipient vessel dissections may be less hostile, etc. It is likely there are systematic differences between studies because there are outliers in the meta-analyses (Figures 2 and 3 ) but the origin is unclear. Alternatively, the observed superiority of mapping may be due to statistical heterogeneity, which is high as represented by the I 2 statistic and other factors, given that the original estimates were not adjusted for potential
confounders. All such methodological biases were observed in the included studies, as depicted in the traffic light system alongside each forest plot. Whilst we used a random-effects model to generate conservative estimates and better accommodate the observed heterogeneity, readers should be cautious interpreting our data as we feel that the data is most useful for hypothesis genesis, rather than decision-making. As three articles (Table 1) did not detail the parameters of the CTA it is impossible to replicate their methods and as such, the usefulness of the data is reduced.
Conclusions
We have shown that the quality of evidence regarding perforator mapping for DIEP flap breast reconstruction is poor and as such, our findings have limited external validity. Whilst our review suggests that preoperative perforator mapping in DIEP flap breast reconstruction reduces operating time and morbidity, which is consistent with the evolving literature, we conclude that higher quality data is needed from well-designed and conducted randomised trials. 
